Samsung to launch AI Health Coach beta in US by year-end
At the Galaxy Tech Forum held in New York on Thursday, Samsung introduced the new feature, which uses AI to analyze users' daily health data collected from wearable devices and provide personalized health care guidance.
'We will release a beta version of the AI Health Coach that supports users in implementing doctors' recommendations through Galaxy Watch and mobile devices,' said Park Heon-soo, head of the Digital Health Team at Samsung.
The feature will initially launch in the US by the end of the year, with no release date yet announced for Korea. According to Samsung, it will be integrated into the Samsung Health app as a chatbot, connecting wearable devices with broader health care infrastructure.
Park emphasized the importance of digital health care solutions that go beyond clinical visits.
'When patients see a doctor, they receive prescriptions — such as losing weight, taking medication, or monitoring blood pressure — but often fail to follow through once they return home. Helping people adhere to those prescriptions in daily life is where digital health begins,' he said.
Samsung also plans to integrate an AI-powered health insight engine into its platform. It will analyze users' health data, including medical records, to provide comprehensive insights. If abnormalities are detected, the system will deliver optimized coaching via a generative AI chatbot.
To protect sensitive personal data, Samsung will adopt a hybrid privacy strategy that processes information both on-device and in the cloud.
'We will use a hybrid approach that processes personal data on the device while leveraging the cloud for enhanced performance,' Park said. 'Users will be given the option to choose which data stays on the device and what can be shared to the cloud.'
For monetization, Samsung is considering business-to-business models, including collaboration with Xealth to create revenue streams, as well as subscription-based or bundled services.
Earlier this week, Samsung announced its acquisition of Xealth, a US-based digital health care company. With this acquisition, Samsung aims to integrate its Samsung Health platform to create a unified digital health ecosystem that bridges wellness and clinical data.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
18 hours ago
- Korea Herald
LG AI Research taps machine learning experts as new heads
LG AI Research appointed Lee Hong-lak, vice president and chief scientist of AI, and Lim Woo-hyung, a senior researcher leading its Data Intelligence Lab, as the institute's new co-heads of research on Monday. The appointments follow the departure of former head Bae Kyung-hoon, who left the post after being appointed as Minister of Science and ICT in June. According to LG, Lee is a globally recognized scholar in machine learning and deep learning. Named among the world's top 10 AI researchers, he also serves as a professor of computer science and engineering at the University of Michigan. Lee will lead LG's Global AI Center in Ann Arbor, Michigan, focusing on next-generation AI technologies and global recruitment, LG said. "Lee is expected to help integrate cutting-edge AI advancements into LG's research efforts while identifying top-tier AI talent worldwide," LG said. Joining him as co-head is Lim, an expert in machine learning and speech recognition. Lim has led applied AI research using LG's hyperscale AI model, Exaone, contributing to real-world problem-solving across LG affiliates and industries, LG said. "Lim will oversee the overall operation of the institute in Korea and expand Exaone-based AI services across LG businesses," the company added.
Korea Herald
19 hours ago
- Korea Herald
Naver readies new social platform ThingsBook for US market
As founder Lee Hae-jin returns to lead, Naver doubles down on US expansion with AI, user-centric platforms South Korean internet giant Naver is preparing to enter the crowded US social media market with a new platform, marking the company's boldest push yet into the world's most competitive digital market. The company said Monday it is developing the new user-generated content platform, named ThingsBook, through its US-based subsidiary But the date and the specifics are still under wraps. 'We are developing a platform targeting the US market, but the launch date and the specific details are undecided at this time,' a Naver spokesperson said. is spearheading the development of ThingsBook as part of Naver's efforts to create a service for the global market from the ground up instead of simply adapting popular Korean services for international users. Naver's Webtoon and Band were both launched in the US after achieving success in Korea. Dubbed a 'personal museum,' the new service will allow users to collect, organize and share content based on personal preferences. Naver has opened a LinkedIn page for ThingsBook, describing it as 'a new kind of social media made just for people who love organizing, collecting and sharing their favorite things, from books and movies to travel spots, fashion, food and more.' As it gears up for launch, Naver has begun recruiting brand ambassadors to help promote the platform, with content categories ranging from food and travel to books, games, movies and fashion. Naver's renewed global push follows the return of its founder Lee Hae-jin earlier this year. He was elected chair of the board at Naver in March, reclaiming a leadership role after an eight-year hiatus since stepping down in 2017. In June, Lee visited Silicon Valley and announced the establishment of Naver Ventures, a US-based investment arm. The new investment company aims to invest in AI startups and future technologies, highlighting Naver's ambitions in the US tech sector. With ThingsBook, Naver appears to be focusing on securing high-quality, localized data, which is critical in AI development. During a trip to the US last month, Lee cited user-generated content as a key factor that helped Naver compete against global tech giants like Google in the local search market. He also stressed that securing a wide range of data will be key to gaining an edge in the AI era. ThingsBook will add to Naver's growing portfolio in the US, which includes the Webtoon platform, operated by US subsidiary Webtoon Entertainment, Naver Band, a social media platform that has gained popularity among after-school activity groups, and Poshmark, a US fashion resale platform that was acquired by Naver in 2023.
Korea Herald
19 hours ago
- Korea Herald
CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services
Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery SEOUL, South Korea, July 21, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partnership with ATG Lifetech, a biotechnology company specializing in transcriptome analytics and organoid-based modeling. This collaboration aims to deliver next-generation, precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures across the U.S., Europe, and Asia. Through this partnership, the two companies will co-develop: "ATG Lifetech's disruptive transcriptome and organoid platforms will significantly elevate the scientific fidelity of our preclinical services," said a CorestemChemon spokesperson. "This alliance positions us to compete as a global CRO partner offering best-in-class biological relevance and regulatory readiness." Organoid-based assays are increasingly recognized for their translational advantage, offering up to 5x greater predictive accuracy in toxicity and efficacy screening compared to conventional 2D cell cultures, according to industry benchmarks. When integrated with whole-transcriptome analysis, these platforms enable earlier go/no-go decisions in drug pipelines, helping clients de-risk clinical entry and reduce overall development timelines. "Investors should note that this partnership directly supports CorestemChemon's strategic growth plan to expand high-margin, IP-driven CRO services globally. Revenue-generating service offerings are expected to begin rolling out by late 2025, with significant global demand already projected." ATG Lifetech brings validated expertise from its international collaborations, including with ACROBiosystems (Switzerland), and has been selected as a core developer in several South Korean government-backed biopharma initiatives. The two companies plan to showcase their joint research outputs at a major toxicology and preclinical science conference in Q4 2025. Global service launches will follow, focused on biotech and pharmaceutical customers in need of high-content, biologically faithful preclinical testing. CorestemChemon (KOSDAQ: 166480) is a full-service preclinical CRO with over two decades of experience in GLP-based toxicology, pharmacokinetics, and regulatory compliance. The company operates multiple AAALAC-certified facilities and partners with leading biopharmaceutical innovators across Asia, the U.S., and Europe.
